YAMAMOTO, Yuji et al.
 Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.
<strong>Vascular Cell</strong>, [S.l.], v. 6, n. 1, p. 18, sep. 2014.
ISSN 2045-824X.
Available at: &lt;<a href="https://vascularcell.com/index.php/vc/article/view/10.1186-2045-824X-6-18" target="_new">https://vascularcell.com/index.php/vc/article/view/10.1186-2045-824X-6-18</a>&gt;. Date accessed: 24 apr. 2024.
doi: <a href="http://dx.doi.org/10.1186/2045-824X-6-18">http://dx.doi.org/10.1186/2045-824X-6-18</a>.